NeuroVision Imaging
Latest round
- Series C
Last raised
- May 2018
Total raised
- $11M
Investors
- 5
About NeuroVision Imaging
Founded in 2010 and based in California, US, NeuroVision Imaging, Inc. operates as a retinal imaging platform that diagnoses Alzheimer’s disease. The company was founded by its CEO, Steven R. Verdooner, and Keith Black. NeuroVision Imaging provides neurology diagnostics and managed telehealth services.net, a telehealth platform that offers evidence-based interventions to support individuals with Alzheimer's disease or other cognitive impairments; and Afina Retinal Imaging, which is cloud-based AI software that uses retinal imaging (taking pictures of the retina) to identify signs of Alzheimer's disease and Cerebral Amyloid Angiopathy (CAA). The company collaborates with health systems, national testing labs, and pharma companies to provide diagnostic biomarkers and digital therapeutic services.
Who invested in NeuroVision Imaging
5 investors across 1 round
See all investors in NeuroVision Imaging
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
May 2, 2018
Amount
$11M
Investors
Questions about NeuroVision Imaging
Who invested in NeuroVision Imaging?
NeuroVision Imaging has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NeuroVision Imaging raised?
NeuroVision Imaging has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NeuroVision Imaging last raise money?
NeuroVision Imaging's most recent round on record is a Series C, in May 2018.
What does NeuroVision Imaging do?
Founded in 2010 and based in California, US, NeuroVision Imaging, Inc.
Where is NeuroVision Imaging headquartered?
NeuroVision Imaging is headquartered in Sacramento, US.
Which VCs invest in companies like NeuroVision Imaging?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at NeuroVision Imaging's stage. Their profiles are linked below.
VCs backing software startups at Series C
Raising like NeuroVision Imaging? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.